Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2025-12-26 @ 4:17 AM
NCT ID: NCT01229527
Description: None
Frequency Threshold: 3.33
Time Frame: None
Study: NCT01229527
Study Brief: Comparison Between Two Different Dosages of Remifentanil During Colonoscopy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Remifentanil RS1 None None None 0 30 7 30 View
Remifentanil RS2 None None None 0 30 9 30 View
Meperidine None None None 0 30 16 30 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hypotension None Vascular disorders None View
Bradycardia None Cardiac disorders None View
Desaturation None Respiratory, thoracic and mediastinal disorders None View
Dizziness None Ear and labyrinth disorders None View
Headache None Nervous system disorders None View
Disinhibition None Psychiatric disorders None View
Amnesia None Nervous system disorders None View
Nausea None Gastrointestinal disorders None View